HCAT Quote, Financials, Valuation and Earnings

AMN Healthcare Services, Inc. has a net margin of -29.13% compared to Health Catalyst, Inc.'s net margin of 4.62%. Health Catalyst, Inc.'s return on equity of -30.29% beat AMN Healthcare Services, Inc.'s return on equity of -38.65%.

Health Catalyst, Inc. has a consensus price target of $3.94, signalling upside risk potential of 46.63%. On the other hand AMN Healthcare Services, Inc. has an analysts' consensus of $20.71 which suggests that it could grow by 25.01%. Given that Health Catalyst, Inc. has higher upside potential than AMN Healthcare Services, Inc., analysts believe Health Catalyst, Inc. is more attractive than AMN Healthcare Services, Inc..

Health Catalyst, Inc. has a beta of 1.723, which suggesting that the stock is 72.331% more volatile than S&P 500. In comparison AMN Healthcare Services, Inc. has a beta of 0.213, suggesting its less volatile than the S&P 500 by 78.742%.

Health Catalyst, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AMN Healthcare Services, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst, Inc. pays -- of its earnings as a dividend. AMN Healthcare Services, Inc. pays out -- of its earnings as a dividend.

Health Catalyst, Inc. quarterly revenues are $76.3M, which are smaller than AMN Healthcare Services, Inc. quarterly revenues of $634.5M. Health Catalyst, Inc.'s net income of -$22.2M is lower than AMN Healthcare Services, Inc.'s net income of $29.3M. Notably, Health Catalyst, Inc.'s price-to-earnings ratio is -- while AMN Healthcare Services, Inc.'s PE ratio is 18.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst, Inc. is 0.58x versus 0.23x for AMN Healthcare Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Humana, Inc. has a net margin of -29.13% compared to Health Catalyst, Inc.'s net margin of 0.59%. Health Catalyst, Inc.'s return on equity of -30.29% beat Humana, Inc.'s return on equity of 7.3%.

Health Catalyst, Inc. has a consensus price target of $3.94, signalling upside risk potential of 46.63%. On the other hand Humana, Inc. has an analysts' consensus of $287.08 which suggests that it could grow by 13.46%. Given that Health Catalyst, Inc. has higher upside potential than Humana, Inc., analysts believe Health Catalyst, Inc. is more attractive than Humana, Inc..

Health Catalyst, Inc. has a beta of 1.723, which suggesting that the stock is 72.331% more volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.462, suggesting its less volatile than the S&P 500 by 53.84%.

Health Catalyst, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana, Inc. offers a yield of 1.4% to investors and pays a quarterly dividend of $0.89 per share. Health Catalyst, Inc. pays -- of its earnings as a dividend. Humana, Inc. pays out 35.45% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Health Catalyst, Inc. quarterly revenues are $76.3M, which are smaller than Humana, Inc. quarterly revenues of $32.6B. Health Catalyst, Inc.'s net income of -$22.2M is lower than Humana, Inc.'s net income of $194M. Notably, Health Catalyst, Inc.'s price-to-earnings ratio is -- while Humana, Inc.'s PE ratio is 23.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst, Inc. is 0.58x versus 0.24x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Option Care Health, Inc. has a net margin of -29.13% compared to Health Catalyst, Inc.'s net margin of 3.61%. Health Catalyst, Inc.'s return on equity of -30.29% beat Option Care Health, Inc.'s return on equity of 15.16%.

Health Catalyst, Inc. has a consensus price target of $3.94, signalling upside risk potential of 46.63%. On the other hand Option Care Health, Inc. has an analysts' consensus of $35.30 which suggests that it could grow by 16.66%. Given that Health Catalyst, Inc. has higher upside potential than Option Care Health, Inc., analysts believe Health Catalyst, Inc. is more attractive than Option Care Health, Inc..

Health Catalyst, Inc. has a beta of 1.723, which suggesting that the stock is 72.331% more volatile than S&P 500. In comparison Option Care Health, Inc. has a beta of 0.796, suggesting its less volatile than the S&P 500 by 20.434%.

Health Catalyst, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst, Inc. pays -- of its earnings as a dividend. Option Care Health, Inc. pays out -- of its earnings as a dividend.

Health Catalyst, Inc. quarterly revenues are $76.3M, which are smaller than Option Care Health, Inc. quarterly revenues of $1.4B. Health Catalyst, Inc.'s net income of -$22.2M is lower than Option Care Health, Inc.'s net income of $51.8M. Notably, Health Catalyst, Inc.'s price-to-earnings ratio is -- while Option Care Health, Inc.'s PE ratio is 24.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst, Inc. is 0.58x versus 0.91x for Option Care Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx Corp. has a net margin of -29.13% compared to Health Catalyst, Inc.'s net margin of 2.99%. Health Catalyst, Inc.'s return on equity of -30.29% beat OptimizeRx Corp.'s return on equity of 0.03%.

Health Catalyst, Inc. has a consensus price target of $3.94, signalling upside risk potential of 46.63%. On the other hand OptimizeRx Corp. has an analysts' consensus of $24.33 which suggests that it could grow by 69.93%. Given that OptimizeRx Corp. has higher upside potential than Health Catalyst, Inc., analysts believe OptimizeRx Corp. is more attractive than Health Catalyst, Inc..

Health Catalyst, Inc. has a beta of 1.723, which suggesting that the stock is 72.331% more volatile than S&P 500. In comparison OptimizeRx Corp. has a beta of 1.099, suggesting its more volatile than the S&P 500 by 9.906%.

Health Catalyst, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst, Inc. pays -- of its earnings as a dividend. OptimizeRx Corp. pays out -- of its earnings as a dividend.

Health Catalyst, Inc. quarterly revenues are $76.3M, which are larger than OptimizeRx Corp. quarterly revenues of $26.1M. Health Catalyst, Inc.'s net income of -$22.2M is lower than OptimizeRx Corp.'s net income of $779K. Notably, Health Catalyst, Inc.'s price-to-earnings ratio is -- while OptimizeRx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst, Inc. is 0.58x versus 2.46x for OptimizeRx Corp.. Usually stocks with elevated PS ratios are considered overvalued.